Nova Patents
PL3453402T3

Reducing immunogenicity against factor viii in individuals undergoing factor viii therapy

Abstract

This record has no abstract on file.

Term

6.3 yearsto projected expiry

Projected expiry 12 January 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

59 members in 23 offices

This recordMember, by publication datePriority claim13 more offices are in the list below

Priority claims17

Priority claims
DocumentOfficeKindDate
201261586103United States of AmericaP
201261586103United States of AmericaP
201261668961United States of AmericaP
201261668961United States of AmericaP
13735995European Patent Office (EPO)A
13735995European Patent Office (EPO)A
18183272European Patent Office (EPO)A
2013021332United States of AmericaW
2013021332United States of AmericaW
181832726–––
201261586103P–––
201261668961P–––
EP20130735995–––
EP20180183272–––
US201261586103P–––
US201261668961P–––
WO2013US21332–––

Members59

Family members, oldest first
DocumentOfficeKind
CA2863329A1CanadaA1
WO2013106789A1World Intellectual Property Organization (WIPO)A1
AU2013204237A1AustraliaA1
IL233565A0IsraelA0
IL233565D0IsraelD0
EP2802668A1European Patent Office (EPO)A1
US2014370035A1United States of AmericaA1
CN104254614AChinaA
JP2015504898AJapanA
EA201491211A1Eurasian Patent Organization (EAPO)A1
EP2802668A4European Patent Office (EPO)A4
NZ627078ANew ZealandA
AU2016210768A1AustraliaA1
AU2013204237B2AustraliaB2
AU2013204237A8AustraliaA8
BR112014017111A2BrazilA2
JP2017149784AJapanA
EA201790221A1Eurasian Patent Organization (EAPO)A1
JP6234378B2JapanB2
EA029560B1Eurasian Patent Organization (EAPO)B1
BR112014017111A8BrazilA8
EP2802668B1European Patent Office (EPO)B1
CN108465106AChinaA
DK2802668T3DenmarkT3
TR2018016253T4TürkiyeT4
TR201816253T4TürkiyeT4
LT2802668TLithuaniaT
PT2802668TPortugalT
AU2016210768B2AustraliaB2
AU2018267631A1AustraliaA1
HRP20181714T1CroatiaT1
SMT201800586T1San MarinoT1
JP6462044B2JapanB2
RS57936B1SerbiaB1
SI2802668T1SloveniaT1
ES2700583T3SpainT3
US10221455B2United States of AmericaB2
EP3453402A1European Patent Office (EPO)A1
PL2802668T3PolandT3
JP2019077690AJapanA
HUE041595T2HungaryT2
US2019241960A1United States of AmericaA1
CY1121157T1CyprusT1
JP2021020950AJapanA
JP6868605B2JapanB2
IL233565AIsraelA
IL233565BIsraelB
EP3453402B1European Patent Office (EPO)B1
AU2018267631B2AustraliaB2
EA038705B1Eurasian Patent Organization (EAPO)B1
PT3453402TPortugalT
ES2899848T3SpainT3
PL3453402T3This recordPolandT3
EP3970737A1European Patent Office (EPO)A1
US11286528B2United States of AmericaB2
CN108465106BChinaB
CA2863329CCanadaC
US2023002828A1United States of AmericaA1
US12371747B2United States of AmericaB2